Pmv Pharmaceuticals Inc (PMVP) Directors and Executive Officers - CSIMarket
CSIMarket
 
Pmv Pharmaceuticals Inc   (NASDAQ: PMVP)

Pmv Pharmaceuticals Inc

Officers & Directors


David H. Mack, Ph.D.
President, Chief Executive Officer, and Director (Principal Executive Officer)

Michael Carulli
Chief Financial Officer (Principal Financial and Accounting Officer)

Richard Heyman, Ph.D.
Director and Chairman of the Board of Directors

Laurie Stelzer
Director

Kirsten Flowers
Director

Carol Gallagher, Ph.D.
Director

Charles M. Baum, M.D., Ph.D.
Director

Arnold Levine, Ph.D.
Director ,

Pmv Pharmaceuticals Inc currently has 54 employees.

  News about Pmv Pharmaceuticals Inc Key Personnel

PMV Pharmaceuticals Reinforces Leadership Team: Spearheading Transformative Cancer Therapies

PMV Pharmaceuticals: Bolstering Leadership for Late-Stage Development Success
PMV Pharmaceuticals, a pioneering precision oncology company specializing in the development of small molecule therapies targeting p53, has recently made strategic appointments to its leadership team. These key additions come as the company advances into late-stage development, solidifying its position as a frontrunner in the field of cancer research.
As the significance of precision medicine continues to gain momentum in the pharmaceutical industry, PMV Pharmaceuticals stands at the forefront, leading the charge in the discovery and development of tumor-agnostic therapies. By targeting the p53 protein, which is frequently ...






PMVP Management Effectiveness PMVP Revenue per Employee PMVP Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.